Skip to main content
logo
JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.200
+0.010 (0.46%)
Sep 18, 2026, 4:08 PM HKT

HKG:2126 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
288.66283.65158.22173.86145.730.8
Revenue Growth
1.76%79.28%-9.00%19.32%373.11%-
Gross Profit
165.67173.0877.3288.2258.769.05
Operating Income
-222.8-243.88-459.03-570.15-697.18-771.72
Net Income
-338.45-555.29-590.62-768-846.14-702.33
Earnings Per Share
-0.81-1.34-1.43-1.87-2.06-1.76
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
392.09503.22762.531,0111,3891,835
Total Debt
254.89262.56422.4318.8279.13147.04
Net Cash (Debt)
137.2240.66340.13692.651,1101,688
Net Cash Growth
-42.99%-29.24%-50.90%-37.59%-34.26%-32.69%
Net Cash Per Share
0.330.580.821.682.714.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--76.85-333.44-398.42-536.72-561.2
Capital Expenditures
--1.38-5.22-12.41-76.87-73.09
Free Cash Flow
--78.23-338.67-410.83-613.6-634.29
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
57.39%61.02%48.87%50.74%40.33%29.37%
Operating Margin
-77.18%-85.98%-290.13%-327.94%-478.49%-2505.82%
Pretax Margin
-116.19%-194.68%-373.30%-441.74%-580.73%-2280.51%
Profit Margin
-117.25%-195.76%-373.30%-441.74%-580.73%-2280.51%
FCF Margin
--27.58%-214.05%-236.30%-421.13%-2059.57%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.683.233.084.7410.57141.07